Department of Rheumatology and Immunology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.
Centre of Neurological and Metabolic Research, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.
Expert Rev Mol Med. 2022 Mar 17;24:e12. doi: 10.1017/erm.2021.33.
Rheumatoid arthritis (RA) is a heterogeneous autoimmune disorder that leads to severe joint deformities, negatively affecting the patient's quality of life. Extracellular vesicles (EVs), which include exosomes and ectosomes, act as intercellular communication mediators in several physiological and pathological processes in various diseases including RA. In contrast, EVs secreted by mesenchymal stem cells perform an immunomodulatory function and stimulate cartilage repair, showing promising therapeutic results in animal models of RA. EVs from other sources, including dendritic cells, neutrophils and myeloid-derived suppressor cells, also influence the biological function of immune and joint cells. This review describes the role of EVs in the pathogenesis of RA and presents evidence supporting future studies on the therapeutic potential of EVs from different sources. This information will contribute to a better understanding of RA development, as well as a starting point for exploring cell-free-based therapies for RA.
类风湿关节炎(RA)是一种异质性自身免疫性疾病,可导致严重的关节畸形,严重影响患者的生活质量。细胞外囊泡(EVs)包括外泌体和胞外体,在 RA 等多种疾病的多种生理和病理过程中充当细胞间通讯介质。相比之下,间充质干细胞分泌的 EVs 具有免疫调节功能,并刺激软骨修复,在 RA 的动物模型中显示出有希望的治疗效果。来自其他来源的 EVs,包括树突状细胞、中性粒细胞和髓系来源的抑制细胞,也会影响免疫和关节细胞的生物学功能。本文综述了 EVs 在 RA 发病机制中的作用,并提供了支持来自不同来源的 EVs 在治疗潜力方面的未来研究的证据。这些信息将有助于更好地了解 RA 的发展,并为探索基于无细胞的 RA 治疗方法提供起点。